Here's how the top cannabis companies stack up to one another on sales.
The Trump administration has unveiled a plan to deliver on his campaign promise to take on big pharmaceutical companies.
Here are six stocks that could pop or drop in 2019 based on these fast-approaching catalysts.
The health insurer's quarterly performance and outlook sparked industry watchers' enthusiasm.
Marijuana is still illegal in the U.S. federally, but medical use is legal in many states, and one new drug is available nationwide by prescription.
Canada's top cannabis company shot higher this week because of growing optimism over its U.S. strategy.
These tips could help put you in a better position to achieve financial security in your golden years.
It could be the perfect time to add this pot stock to portfolios.
Here's why these mid-cap stocks look enticing.
Long-tail opportunities make these top stocks great for long-term portfolios.
If you're married or divorced, spousal benefits could be key to achieving financial security in retirement.
Financial results for MedMen, one of the country's leading dispensary companies, suggest this market is on the cusp of a major opportunity.
There's been a lot going on over these past couple of months with the cannabis and marijuana industry.
These top marijuana stocks could have market-moving news on deck soon.
The marijuana heavyweight has announced a revolutionary new agreement to create a hub of hemp innovation in New York.
These fast-growing stocks target massive markets that could make them some of the market's best growth stocks.
Clinical-trial and regulatory-review decisions make these three drug developers worth keeping tabs on this year.
The developer of a new cholesterol-lowering treatment is on a path toward commercialization.
These companies arguably stole the show at J.P. Morgan's high-profile healthcare conference this year.
These stocks skyrocketed following exciting announcements.